Assurance report on the deposit and use of raised funds in Jiangsu Chinagreen Biological Technology Co.Ltd(300970) 2021
Zhitong Certified Public Accountants (special general partnership)
catalogue
Assurance report on the deposit and use of raised funds in Jiangsu Chinagreen Biological Technology Co.Ltd(300970) 2021
Jiangsu Chinagreen Biological Technology Co.Ltd(300970) 2021 raised funds 1-3
Special report on storage and actual use
Zhitong Certified Public Accountants (special general partnership), 5th floor, set square, No. 22, Jianguomenwai street, Chaoyang District, Beijing, China, 100004
Tel. + 86 1085665588
Fax + 86 1085665120
www.grantthornton. cn.
About Jiangsu Chinagreen Biological Technology Co.Ltd(300970)
Deposit and actual use of raised funds in 2021
Assurance Report
Zhi Tong Zhi Zi (2022) No. 371a005600 Jiangsu Chinagreen Biological Technology Co.Ltd(300970) all shareholders:
We are entrusted to carry out reasonable assurance on the attached special report on the deposit and actual use of raised funds in 2021 (hereinafter referred to as the “special report”) of Jiangsu Jiangsu Chinagreen Biological Technology Co.Ltd(300970) Technology Co., Ltd. (hereinafter referred to as “the company”).
It is the responsibility of the board of directors of Jiangsu Chinagreen Biological Technology Co.Ltd(300970) company to prepare the special report for 2021 in accordance with the requirements of self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM to ensure that its contents are true, accurate and complete and there are no false records, misleading statements or major omissions, Our responsibility is to express assurance opinions on the 2021 special report prepared by the board of directors of Jiangsu Chinagreen Biological Technology Co.Ltd(300970) company on the basis of the implementation of assurance work.
We plan and implement the assurance work in accordance with the provisions of other assurance business standards for Chinese certified public accountants No. 3101 – assurance business other than audit or review of historical financial information, so as to obtain reasonable assurance about whether there is no material misstatement in the special report in 2021. In the assurance work, we implemented the necessary procedures including understanding, inquiry, spot check, check and so on in combination with the actual situation of Jiangsu Chinagreen Biological Technology Co.Ltd(300970) company. We believe that our assurance work provides a reasonable basis for issuing assurance opinions.
After review, we believe that the 2021 special report prepared by the board of directors of Jiangsu Chinagreen Biological Technology Co.Ltd(300970) company complies with the relevant provisions of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM and the relevant format guidelines, and truthfully reflects the deposit and actual use of the raised funds of Jiangsu Chinagreen Biological Technology Co.Ltd(300970) company in 2021 in all major aspects.
This assurance report is only for use when Jiangsu Chinagreen Biological Technology Co.Ltd(300970) company discloses its annual report and shall not be used for any other purpose. Zhitong certified public accountants China Certified Public Accountants
(special general partnership)
Chinese certified public accountant
Beijing, China April 8, 2002
Jiangsu Chinagreen Biological Technology Co.Ltd(300970)
Special report on the deposit and use of raised funds in 2021
In accordance with the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022), the guidelines for the self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM and relevant format guidelines, The board of directors of Jiangsu Chinagreen Biological Technology Co.Ltd(300970) (hereinafter referred to as “the company”) prepared a special report on the annual deposit and actual use of raised funds in 2021.
1、 Basic information of raised funds
(I) actual amount of funds raised and time of funds in place
With the approval of China Securities Regulatory Commission’s zjxk [2021] No. 757 and with the consent of Shenzhen Stock Exchange, the company publicly issued 14.59 million ordinary shares (A shares) to the public by Citic Securities Company Limited(600030) through the system of Shenzhen Stock Exchange on March 29, 2021 by pricing and placing all the shares to investors in the secondary market, with an issue price of 44.77 yuan per share. As of April 2, 2021, the company had raised a total of 6531943 million yuan, and the net amount raised after deducting the issuance expenses was 5961098 million yuan.
The above-mentioned net amount of raised funds has been verified in the capital verification report of Grant Thornton Certified Public Accountants (special general partnership) YZ (2021) No. 371c000160.
(II) amount used and current balance in the current year
As of December 31, 2021, the accumulated investment of the raised funds was 2.1632 million yuan, and the unused amount was 5939466 million yuan.
2、 Deposit and management of raised funds
(I) management of raised funds
In order to protect the rights and interests of the company and improve the efficiency of the use of funds raised by the Shenzhen Stock Exchange (hereinafter referred to as the “management system of funds raised by the stock exchange”).
In accordance with the management system and in combination with the business needs, the company implements a special account for the raised funds, and signed the tripartite supervision agreement for the raised funds with the deposit bank and the recommendation institution in April 2021 and December 2021 respectively
And the supervision agreement on raised funds, which defines the rights and obligations of all parties, and strictly approves the use of raised funds to ensure that the special funds are used for special purposes. In 2021, the company deposited and used the raised funds in strict accordance with the provisions of the raised funds supervision agreement.
(II) storage of raised funds in special account
As of December 31, 2021, the specific deposit of the company’s raised funds (unit: RMB) is as follows: unit: RMB
Deposit bank account number account category storage balance
China China Minsheng Banking Corp.Ltd(600016) Co., Ltd. has 632816542 deposit accounts for Siyang sub branch of non budget unit 9882590179 Co., Ltd
Bank Of Communications Co.Ltd(601328) Co., Ltd. 39889999101 Jiangsu Xinning Modern Logistics Co.Ltd(300013) 7167 deposit account for Suqian branch of special 19291425032 company of non budget unit
China Merchants Bank Co.Ltd(600036) Co., Ltd. 125912733610902 deposit account for Nanjing Zhujiang Road sub branch of special 0.00 company of non budget unit
China Citic Bank Corporation Limited(601998) Co., Ltd. 8110501013 China Telecom Corporation Limited(601728) 051 non budget unit special 0.00 company Nanjing Wangfu sub branch deposit account
China Merchants Bank Co.Ltd(600036) Co., Ltd. 125913843310501 non budget unit special 29754302155 company Nanjing Zhujiang Road sub branch deposit account
China Agricultural Bank Of China Limited(601288) Co., Ltd. has 5051810104 Rongsheng Petro Chemical Co.Ltd(002493) 8 non budget unit special 1563042155 limited company Wangdu County sub branch deposit account
Total 60491359521
Among the above deposit balances, 10.968 million yuan of interest has been included in the special account for raised funds (including 10.968 million yuan of interest income in 2021), and 11000 yuan of handling charges have been deducted (including 11000 yuan of handling charges in 2021). 3、 Actual use of raised funds this year
(I) use of funds for investment projects with raised funds
The actual use of the raised funds in this year is detailed in Annex 1: comparison table of the use of the raised funds.
(II) changes in the place and mode of implementation of the project invested with raised funds.
The tenth meeting of the Fourth Board of directors, the ninth meeting of the Fourth Board of supervisors and the third extraordinary general meeting of shareholders held on October 28, 2021 considered and adopted the proposal on changing the purpose of some raised funds, It is agreed to change the “project with an annual output of 30000 tons of Apodemus agrarius” in the investment project of the initial raised funds into “the industrialized production project with an annual output of 54000 tons of fresh Flammulina velutipes of Hebei hualvzhizhen Biotechnology Co., Ltd.” and the project location is changed from Siyang County, Jiangsu Province to Wangdu County, Hebei Province.
(III) advance investment and replacement of investment projects with raised funds.
The investment projects of the company’s raised funds have not been invested in advance.
(IV) temporary replenishment of working capital with idle raised funds.
As of December 31, 2021, the company did not temporarily supplement working capital with idle raised funds. (V) use of surplus raised funds.
As of December 31, 2021, the company has not used the raised funds for investment projects and the surplus funds for other raised funds investment projects or non raised funds investment projects.
(VI) use of over raised funds.
As of December 31, 2021, the company has no use of over raised funds.
(VII) purpose and destination of unused raised funds.
As of December 31, 2021, the unused raised funds of 459 million yuan had purchased principal guaranteed financial products in the special account for raised funds, and the rest of the raised funds were deposited in the special account.
(VIII) other information about the use of raised funds.
Except for the above matters, the company has no other use of the raised funds.
4、 Change the use of funds of raised investment projects
As of December 31, 2021, “Hebei hualvzhizhen Biotechnology Co., Ltd. has an annual output of 54000 tons of fresh Flammulina velutipes industrialized production project”, with a cumulative use of raised funds of 2.1632 million yuan.
5、 Problems in the use and disclosure of raised funds
The company uses the raised funds in accordance with the provisions and requirements of relevant laws, regulations and normative documents, and timely discloses the use of the raised funds. There are no violations in the storage, use and management of the raised funds.
Jiangsu Chinagreen Biological Technology Co.Ltd(300970) board of directors April 8, 2022
Annex 1:
Comparison table of use of raised funds
Deadline: December 31, 2021
